Tata Elxsi Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 10:26 am

Quick Insight

Tata Elxsi Ltd, a prominent player in the IT Consulting & Software industry, currently trades at a price of ₹5,478 with a market capitalization of ₹34,126 Cr. The company's high P/E ratio of 45.8 indicates market confidence in its growth prospects. With robust returns on equity (ROE) at 29.3% and returns on capital employed (ROCE) at 36.3%, Tata Elxsi demonstrates efficient capital utilization. Moreover, a healthy operating profit margin (OPM) of 21% and a strong interest coverage ratio (ICR) of 72264.96x underscore the company's financial stability. However, the relatively high price-to-book value (P/BV) ratio of 12.72x warrants further scrutiny into the stock's valuation. Investors should closely monitor Tata Elxsi's operational efficiency and debt levels given its borrowing of ₹196 Cr and a moderate current ratio of 95 days.

Competitors of Tata Elxsi Ltd

All Competitor Stocks of Tata Elxsi Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:25 pm

Below is a detailed analysis of the quarterly data for Tata Elxsi Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 892.00 Cr.. The value appears to be declining and may need further review. It has decreased from 908.00 Cr. (Mar 2025) to 892.00 Cr., marking a decrease of 16.00 Cr..
• For Expenses, as of Jun 2025, the value is 705.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 701.00 Cr. (Mar 2025) to 705.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 187.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 187.00 Cr., marking a decrease of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 21.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 221.00 Cr. (Mar 2025) to 196.00 Cr., marking a decrease of 25.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 26.00%, marking an increase of 4.00%.
• For Net Profit, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 172.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 28.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 23.18. The value appears to be declining and may need further review. It has decreased from 27.68 (Mar 2025) to 23.18, marking a decrease of 4.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:51 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:09 pm

Below is a detailed analysis of the balance sheet data for Tata Elxsi Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 62.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,798.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,443.00 Cr. (Mar 2024) to 2,798.00 Cr., marking an increase of 355.00 Cr..
• For Borrowings, as of Mar 2025, the value is 196.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 225.00 Cr. (Mar 2024) to 196.00 Cr., marking a decrease of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 529.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 457.00 Cr. (Mar 2024) to 529.00 Cr., marking an increase of 72.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,586.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,187.00 Cr. (Mar 2024) to 3,586.00 Cr., marking an increase of 399.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 318.00 Cr.. The value appears to be declining and may need further review. It has decreased from 396.00 Cr. (Mar 2024) to 318.00 Cr., marking a decrease of 78.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,266.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,789.00 Cr. (Mar 2024) to 3,266.00 Cr., marking an increase of 477.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,586.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,187.00 Cr. (Mar 2024) to 3,586.00 Cr., marking an increase of 399.00 Cr..

Notably, the Reserves (2,798.00 Cr.) exceed the Borrowings (196.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Tata Elxsi Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 15, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 14) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
• For Diluted EPS (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
• For Cash EPS (Rs.), as of Mar 15, the value is 40.97. This value is within the healthy range. It has increased from 34.44 (Mar 14) to 40.97, marking an increase of 6.53.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 91.02. It has increased from 75.70 (Mar 14) to 91.02, marking an increase of 15.32.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 91.02. It has increased from 75.70 (Mar 14) to 91.02, marking an increase of 15.32.
• For Revenue From Operations / Share (Rs.), as of Mar 15, the value is 272.78. It has increased from 248.82 (Mar 14) to 272.78, marking an increase of 23.96.
• For PBDIT / Share (Rs.), as of Mar 15, the value is 58.02. This value is within the healthy range. It has increased from 47.85 (Mar 14) to 58.02, marking an increase of 10.17.
• For PBIT / Share (Rs.), as of Mar 15, the value is 49.82. This value is within the healthy range. It has increased from 36.62 (Mar 14) to 49.82, marking an increase of 13.20.
• For PBT / Share (Rs.), as of Mar 15, the value is 49.82. This value is within the healthy range. It has increased from 36.03 (Mar 14) to 49.82, marking an increase of 13.79.
• For Net Profit / Share (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
• For NP After MI And SOA / Share (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
• For PBDIT Margin (%), as of Mar 15, the value is 21.26. This value is within the healthy range. It has increased from 19.23 (Mar 14) to 21.26, marking an increase of 2.03.
• For PBIT Margin (%), as of Mar 15, the value is 18.26. This value is within the healthy range. It has increased from 14.71 (Mar 14) to 18.26, marking an increase of 3.55.
• For PBT Margin (%), as of Mar 15, the value is 18.26. This value is within the healthy range. It has increased from 14.47 (Mar 14) to 18.26, marking an increase of 3.79.
• For Net Profit Margin (%), as of Mar 15, the value is 12.01. This value exceeds the healthy maximum of 10. It has increased from 9.32 (Mar 14) to 12.01, marking an increase of 2.69.
• For NP After MI And SOA Margin (%), as of Mar 15, the value is 12.01. This value is within the healthy range. It has increased from 9.32 (Mar 14) to 12.01, marking an increase of 2.69.
• For Return on Networth / Equity (%), as of Mar 15, the value is 35.99. This value is within the healthy range. It has increased from 30.65 (Mar 14) to 35.99, marking an increase of 5.34.
• For Return on Capital Employeed (%), as of Mar 15, the value is 52.72. This value is within the healthy range. It has increased from 46.03 (Mar 14) to 52.72, marking an increase of 6.69.
• For Return On Assets (%), as of Mar 15, the value is 21.91. This value is within the healthy range. It has increased from 18.60 (Mar 14) to 21.91, marking an increase of 3.31.
• For Total Debt / Equity (X), as of Mar 15, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 14) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 15, the value is 1.99. It has decreased from 2.06 (Mar 14) to 1.99, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 15, the value is 1.92. This value is within the healthy range. It has increased from 1.69 (Mar 14) to 1.92, marking an increase of 0.23.
• For Quick Ratio (X), as of Mar 15, the value is 1.91. This value is within the healthy range. It has increased from 1.69 (Mar 14) to 1.91, marking an increase of 0.22.
• For Dividend Payout Ratio (NP) (%), as of Mar 15, the value is 33.57. This value is within the healthy range. It has decreased from 38.78 (Mar 14) to 33.57, marking a decrease of 5.21.
• For Dividend Payout Ratio (CP) (%), as of Mar 15, the value is 26.85. This value is within the healthy range. It has increased from 26.13 (Mar 14) to 26.85, marking an increase of 0.72.
• For Earning Retention Ratio (%), as of Mar 15, the value is 66.43. This value is within the healthy range. It has increased from 61.22 (Mar 14) to 66.43, marking an increase of 5.21.
• For Cash Earning Retention Ratio (%), as of Mar 15, the value is 73.15. This value exceeds the healthy maximum of 70. It has decreased from 73.87 (Mar 14) to 73.15, marking a decrease of 0.72.
• For Interest Coverage Ratio (X), as of Mar 15, the value is 72,264.96. This value is within the healthy range. It has increased from 81.56 (Mar 14) to 72,264.96, marking an increase of 72,183.40.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 15, the value is 40,809.36. This value is within the healthy range. It has increased from 40.56 (Mar 14) to 40,809.36, marking an increase of 40,768.80.
• For Enterprise Value (Cr.), as of Mar 15, the value is 3,473.01. It has increased from 1,643.70 (Mar 14) to 3,473.01, marking an increase of 1,829.31.
• For EV / Net Operating Revenue (X), as of Mar 15, the value is 4.09. This value exceeds the healthy maximum of 3. It has increased from 2.12 (Mar 14) to 4.09, marking an increase of 1.97.
• For EV / EBITDA (X), as of Mar 15, the value is 19.22. This value exceeds the healthy maximum of 15. It has increased from 11.03 (Mar 14) to 19.22, marking an increase of 8.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 15, the value is 4.25. This value exceeds the healthy maximum of 3. It has increased from 2.19 (Mar 14) to 4.25, marking an increase of 2.06.
• For Retention Ratios (%), as of Mar 15, the value is 66.42. This value is within the healthy range. It has increased from 61.21 (Mar 14) to 66.42, marking an increase of 5.21.
• For Price / BV (X), as of Mar 15, the value is 12.72. This value exceeds the healthy maximum of 3. It has increased from 7.19 (Mar 14) to 12.72, marking an increase of 5.53.
• For Price / Net Operating Revenue (X), as of Mar 15, the value is 4.25. This value exceeds the healthy maximum of 3. It has increased from 2.19 (Mar 14) to 4.25, marking an increase of 2.06.
• For EarningsYield, as of Mar 15, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 14) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness